Department of Neurosurgery, Humanitas Clinical and Research Center - IRCCS, Rozzano (Mi), Italy.
Department of Neurosurgery, Humanitas Clinical and Research Center - IRCCS, Rozzano (Mi), Italy.
World Neurosurg. 2021 May;149:e92-e100. doi: 10.1016/j.wneu.2021.02.074. Epub 2021 Feb 25.
Trigeminal neuralgia (TN) in patients with multiple sclerosis (MS) is a challenging condition to manage that is treated with Gamma Knife radiosurgery (GKRS). The aim of this report is to assess the safety, efficacy, and durability of GKRS for the treatment of TN in patients with MS. Our findings are compared with those of the existing literature and discussed.
We retrospectively reviewed all patients at our institution who underwent GKRS for the treatment of TN secondary to MS and had 1 or more years of follow-up. Preoperative and postoperative pain intensities and facial numbness were evaluated with the Barrow Neurological Institute scores. Durability of successful pain relief was statistically evaluated with Kaplan-Meier analysis. The prognostic role of perioperative factors was investigated and analyzed using Cox proportional hazards regression.
There were 29 patients with MS-TN who underwent GKRS at our institution. Two patients underwent bilateral treatment. Four patients underwent repeat GKRS for pain recurrence. The median period of follow-up assessment was 33 months. Rates of reasonable pain reduction at 1, 3, and 5 years were 70%, 57%, and 57% respectively. All patients who underwent repeat GKRS had durable pain reduction. No prognostic factor for successful pain reduction was found.
Our study shows that GKRS for the treatment of TN secondary to MS is a safe and effective procedure in controlling pain in the short term but often fails to provide long-term pain control. GKRS can be safely repeated to prolong the time of pain reduction.
多发性硬化症(MS)患者的三叉神经痛(TN)是一种难以治疗的病症,可采用伽玛刀放射外科手术(GKRS)进行治疗。本报告旨在评估 GKRS 治疗 MS 相关 TN 的安全性、疗效和持久性。我们将研究结果与现有文献进行了比较和讨论。
我们回顾性分析了在我们机构接受 GKRS 治疗 MS 继发 TN 且随访时间超过 1 年的所有患者。使用巴罗神经研究所评分评估术前和术后疼痛强度和面部麻木程度。采用 Kaplan-Meier 分析对成功缓解疼痛的持久性进行统计学评估。利用 Cox 比例风险回归分析研究和分析围手术期因素的预后作用。
我们机构共有 29 例 MS-TN 患者接受了 GKRS 治疗,其中 2 例患者接受了双侧治疗,4 例患者因疼痛复发接受了重复 GKRS 治疗。中位随访评估时间为 33 个月。1、3 和 5 年时合理疼痛缓解率分别为 70%、57%和 57%。所有接受重复 GKRS 的患者均获得了持久的疼痛缓解。未发现对疼痛缓解有影响的预后因素。
我们的研究表明,GKRS 治疗 MS 继发的 TN 是一种安全有效的短期控制疼痛的方法,但往往无法提供长期的疼痛控制。可以安全地重复 GKRS 以延长疼痛缓解时间。